$treet Trader Lion's Den

[ChannelTrader]

VDTI, great A/H news....

VitalCare Announces National Launch of Diabetes Treatment Centers National Launch of FDA Approved iCAT Therapy Begins


CARSON CITY, Nev., Apr 22, 2008 (BUSINESS WIRE) --
VitalCare Diabetes Treatment Centers, Inc. (Pink Sheets: VDTI), a
Nevada Corporation, today announced the national launch for opening
licensed diabetes treatment centers utilizing the micro-dose
intravenous insulin pump technology together with proprietary
algorithms and clinical protocols for providing Intercellular
Activation Therapy (iCAT) for treating diabetes.
The iCAT treatment is currently being administered at several
clinics in Arizona, Nevada, Utah, Florida, Texas and Puerto Rico, to
those who suffer from Type 1 and Type 2 Diabetes, in addition to
secondary complications of Type 2 Diabetes including hypertension,
peripheral vascular disease, retinopathy, heart disease, peripheral
neuropathy, kidney disease, and diabetic wounds.
Jimmy McDougald, CEO, stated, "Due to VitalCare's clinical
specialists' succeeding in the treatment of Type 1, Type 2 and
Secondary Complications of Type 2 Diabetes over the past two decades,
our executive board has decided to open opportunities for licensing
VitalCare Diabetes Treatment Centers affiliates with certified
training for qualified healthcare providers, for the licensing and use
of iCAT Therapy. It is VitalCare's goal to make iCAT Therapy more
accessible to the 21 million diabetics in North America. The VitalCare
Diabetes Treatment Centers will either be company owned, joint
ventured or licensed to select qualified medical professionals."
About VitalCare Diabetes Treatment Centers, Inc.
VitalCare Diabetes Treatment Centers, Inc. is a publicly traded
company specializing in providing Administrative, Marketing, Business
Development, Strategic Planning, Clinical Oversight and
Clinical Management Services to the Diabetes Healthcare Sector.
VitalCare will become the premier company bringing diabetes related
medical devices and healthcare services direct to consumers, focusing
on the emerging technology and treatment intervention for treating
Type 1 and Type 2 Diabetes known as "Intercellular Activation Therapy
(iCAT)."
Safe Harbor Statement: Forward-looking statements in this release
with respect to VitalCare Diabetes Treatment Centers, Incorporated's
business, financial condition and results of operations, as well as
matters of timing and the prospective terms of the transaction
described are subject to risks and uncertainties that could cause
actual results to differ materially from those expressed in the
forward- looking statements, including, but not limited to, certain
delays beyond VitalCare Diabetes Treatment Centers, Incorporated's
control with respect to market acceptance of their technology and/or
products, whether financing will be available, the effect of the
application of acquisition accounting policies as well as certain
other risk factors which are and may be detailed from time to time in
VitalCare's filings with the Securities and Exchange Commission.
SOURCE: VitalCare Diabetes Treatment Centers, Inc.
VitalCare Diabetes Treatment Centers, Inc.
Jimmy McDougald
Investor Relations:
Office: 1.877.NO-DIABETES
Office: 1.909.981.9192
Fax: [phone]
Email: [e-mail]